Abstract

The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or significant) on the affected person, there are still not clear enough studies to elucidate their combined effect in this specific treatment, and existing protocols are sometimes unclear and uncertain. In contrast, it has been found that nutraceuticals, supplements, and various herbs can be effective in reducing the chances of SARS-CoV-2 infection, but also in alleviating COVID-19 symptoms. However, not enough specific details are yet available, and precise scientific studies to validate the approved benefits of natural food additives, probiotics, herbs, and nutraceuticals will need to be standardized according to current regulations. These alternative treatments may not have a direct effect on the virus or reduce the risk of infection with it, but these products certainly stimulate the human immune system so that the body is better prepared to fight the disease. This paper aims at a specialized literary foray precisely in the field of these “cures” that can provide real revelations in the therapy of coronavirus infection

Highlights

  • Wuhan (P.R. of China) was the first city where the coronavirus was identified in December 2019 [1]

  • All eligible articles with the potential to be used in this research were chosen according to their keywords, title and/or abstract; subsequently, an analysis of the content was made by applying various filtering techniques as follows: publication language—English, the novelty of the information provided, etc

  • Both dietary and plant-based medicine offer an alternative with recognized potential, very good, effective, and accessible to patients suffering from COVID-19 or in the recovery period after the disease

Read more

Summary

Introduction

Wuhan (P.R. of China) was the first city where the coronavirus was identified in December 2019 [1] It produces a severe acute respiratory disease that has spread dramatically throughout the world, and the World Health Organization (WHO) announced a pandemic on 11 March 2020 [2]. The highest numbers of cases were reported from the United States of America, India, Brazil, Russia, France, United Kingdom, Turkey, with many infected persons and deaths varying daily by continents, regions, and countries [4]. This virus is transferred through aerosol drops [5] affecting the nose, mouth, and eyes of an infected person. Some patients are characterized mainly by dyspnea and hypoxemia, which can gradually evolve into a moderate respiratory condition requiring oxygen treatment

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.